Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Fabrizio Cantini and Emanuele Nicastri.
Fabrizio Cantini
Connection Strength
0.557
Emanuele Nicastri
  1. Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study. J Infect. 2020 10; 81(4):647-679.
    View in: PubMed
    Score: 0.222
  2. Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact. J Infect. 2020 08; 81(2):318-356.
    View in: PubMed
    Score: 0.220
  3. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy. J Infect. 2021 04; 82(4):58-66.
    View in: PubMed
    Score: 0.058
  4. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect. 2021 Feb; 27(2):286.e7-286.e13.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.